Repare Therapeutics Inc.
RPTX
$1.59
$0.042.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 51.85% | -328.26% | -2.29% | -82.24% | -191.09% |
| Total Depreciation and Amortization | 112.30% | 136.73% | -10.28% | -4.02% | -3.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -163.59% | -30.71% | -11.51% | -10.46% | 14.93% |
| Change in Net Operating Assets | 270.73% | 43.02% | 36.12% | 94.17% | 94.04% |
| Cash from Operations | 46.44% | -344.16% | 2.95% | 7.09% | 11.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -108.23% | 241.72% | -2.14% | 26.87% | -75.80% |
| Cash from Investing | -108.23% | 241.72% | -0.92% | 26.87% | -74.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -78.93% | -99.05% | -41.55% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -78.93% | -99.05% | -41.55% | -100.00% |
| Foreign Exchange rate Adjustments | 13,000.00% | -- | -222.54% | 116.09% | -102.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.20% | 96.75% | 7.10% | 108.82% | -295.42% |